Working with techUK, the Science and Technology Facilities Council’s (STFC) Hartree Centre sponsored a series of Big Data in Action Roadshows to demonstrate the value of big data analytics and encourage adoption of these technologies in UK industry.
Revealing the Value of Open Data
The big data and data analytics capabilities of the Hartree Centre and its partner IBM are enabling Democrata to help construction firms predict the presence of archaeological remains.
Transforming traffic modelling with Atkins
In a pioneering collaboration funded by Highways England and Atkins, the STFC Hartree® Centre’s expertise is ensuring that key simulation software can meet the intense demands of a £15 billion road construction and improvement programme.
On-demand supercomputing for innovative technology R&D
Engineering R&D consultancy Menatech Limited have used flexible supercomputing resources at the Hartree Centre, accessed via OCF’s enCORE service, to speed up big data simulations and reduce costs.
Supercomputers are getting to the heart of the matter
At the Hartree Centre, scientists are using our powerful supercomputers to visualise how blood flows through implanted blood pumps.
Next-generation weather model development with the Met Office
The weather might just be the UK’s favourite topic of conversation – probably in part because it is so difficult to predict what it will do next. But making the weather more predictable is precisely what we’re trying to do.
More accurate rail updates using big data analytics
We investigated how big data analytics could be used in the rail transport system to provide real-time service information.
Drip-free design meets need for speed
Using supercomputer Blue Wonder, we helped Unilever slash many months and tens of thousands of pounds from the design process, whilst delivering the best consumer experience for new laundry liquid products.
Pharmaceutical product design goes digital
Working with major names in the industry, the Hartree Centre is a partner in the powerful ADDoPT collaboration that aims to secure the UK’s place at the forefront of new pharmaceutical development.